Sangamo Biosciences reported $-45261000 in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Alnylam Pharmaceuticals ALNY:US $ -146.73M 47.83M
Amgen AMGN:US $ 2500M 196M
Avrobio Inc AVRO:US -29418000 1.46M
Bayer BAYN:GR 4.21B 2.19B
Biocryst Pharmaceuticals BCRX:US $ -49.96M 53.62M
Biogen BIIB:US $ 610.7M 23.6M
Biomarin Pharmaceutical BMRN:US $ 137.33M 203.21M
Bluebird Bio BLUE:US $ -120.35M 15.32M
Gilead Sciences GILD:US $ 197M 743M
GlaxoSmithKline GSK:LN 2.8B 1.91B
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
IONIS PHARMACEUT IONS:US $ -57.5M 278.11M
Johnson & Johnson JNJ:US $ 5862M 1026M
Karyopharm Therapeutics KPTI:US $ -34586000 81.55M
Merk MRK:US $ 5569M 1994M
Novartis NOVN:VX 2.85B 290M
Pfizer PFE:US $ 9873M 5297M
Regulus Therapeutics RGLS:US $ -6.57M 0.39M
Sangamo Biosciences SGMO:US $ -45.26M 5.36M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Ultragenyx Pharmaceutical RARE:US $ -136.63M 34.07M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M
Ziopharm Oncology ZIOP:US $ -9085000 1.97M